SCHEMBL5316566

SCHEMBL5316566

CCCCCCCCCCCCCCCC(=O)NC(CO)CN1CCCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UGCG Q16739 8/20 0.55
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
MAPK1 P28482 2/20 0.53
FAAH O00519 1/20 0.53
DNM1 Q05193 1/20 0.51
CERT1 Q9Y5P4 3/20 0.48
PLA2G2C Q5R387 1/20 0.48
HTR1A P08908 1/20 0.47
PTGS1 P23219 1/20 0.47
OPRM1 P35372 1/20 0.47
PLA2G10 O15496 1/20 0.45
TP53 P04637 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
NFKB1 P19838 1/20 0.44
CYP2C19 P33261 1/20 0.44
HIF1A Q16665 1/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19287146 1.00 UGCG (0.55) UGCGMEN1KMT2AMAPK1FAAH
SCHEMBL19286487 0.89 UGCG (0.44) UGCGMEN1KMT2AMAPK1FAAH
SCHEMBL13493025 0.89 UGCG (0.55) UGCGMEN1KMT2AMAPK1FAAH
SCHEMBL7923582 0.89 UGCG (0.55) UGCGMEN1KMT2AMAPK1FAAH
SCHEMBL19043452 0.82 MEN1 (0.60) UGCGMEN1KMT2AMAPK1FAAH
SCHEMBL19287140 0.82 PLA2G2C (0.45) UGCGMEN1KMT2AMAPK1FAAH
SCHEMBL19287218 0.82 PLA2G2C (0.45) UGCGMEN1KMT2AMAPK1FAAH
SCHEMBL19287215 0.82 PLA2G2C (0.45) UGCGMEN1KMT2AMAPK1FAAH
SCHEMBL23799220 0.81 DNM1 (0.68) MEN1KMT2AMAPK1FAAHDNM1
SCHEMBL14159281 0.81 DNM1 (0.68) MEN1KMT2AMAPK1FAAHDNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007065017-A2 OLIGONUCLEOTIDE CATIONIC LIPOSOMAL DELIVERY SYSTEM PRONAI THERAPEUTICS, INC. (US) 2007-06-07 WO disclosed